IOL Chemicals and Pharmaceuticals posts Q4 FY25 PAT at Rs. 31.42 Cr

IOL Chemicals and Pharmaceuticals has posted net profit of Rs.101.07 crores for the Financial Year ended March 31, 2025

Jubilant Pharmova posts Q4 FY25 consolidated PAT at Rs. 153.6 Cr

Jubilant Pharmova has posted net profit of Rs. 839.4 crores for the Financial Year ended March 31, 2025

Lupin posts consolidated Q4 FY25 PAT at Rs. 772.52 Cr

Sanofi India posts 27% growth in operating profits in Q1 2025

Standalone profit from operations for the quarter were Rs. 162 crores

GlaxoSmithKline Pharmaceuticals posts FY25 PAT at Rs. 915 Cr

The Board of Directors of the company recommends a final dividend of Rs. 42 per equity share for the 12 months period ended March 31, 2025

Artemis Medicare Services posts Q4 FY25 consolidated PAT at Rs. 23.02 Cr

The company has posted net profit of Rs. 82.62 crores for the Financial Year ended March 31, 2025

Krsnaa Diagnostics posts Q4 FY25 consolidated PAT at Rs. 20.67 Cr

The company has posted net profit of Rs. 77.60 crores for the Financial Year ended March 31, 2025

Bliss GVS Pharma posts Q4 FY25 consolidated PAT at Rs. 15.53 Cr

The company has posted net profit of Rs. 84.29 crores for the Financial Year ended March 31, 2025

Poly Medicure posts Q4 FY25 consolidated profit at Rs. 91.83 Cr

The company has posted net profit of Rs. 338.55 crores for the Financial Year ended March 31, 2025

Dabur India posts Q4 FY25 consolidated PAT at Rs. 320.13 Cr

The company has posted net profit of Rs. 1,767.63 crores for the Financial Year ended March 31, 2025